The serum improved hair thickness and density in just eight weeks, faster than typical treatments. (Photo Credit: Pexels)


April 21, 2026 Tags:

A team of scientists has developed a plant-based hair growth serum that has shown promising results in early clinical testing, with noticeable improvements in hair thickness and density within just eight weeks. The findings are drawing attention, particularly because most existing treatments typically require several months to show visible changes.

The study, conducted in Taipei, evaluated whether a carefully designed combination of biological signals and plant-derived compounds could accelerate hair growth in a controlled setting.

Early Results Indicate Faster Improvements

The clinical trial involved 60 adults who participated in a randomized, double-blind study, ensuring that neither the participants nor the researchers knew who received the active treatment or placebo during the test period.

Participants applied one milliliter of the serum to their scalp each night for 56 days. By the end of the study, those using the full formula showed nearly a 25 percent increase in hair thickness compared to the placebo group.

These results are notable because they suggest a faster response than many conventional treatments, which often take longer to produce visible improvements.

What Makes This Serum Different

The formulation combines commonly used ingredients with more advanced biological components. Alongside caffeine and panthenol, which are frequently found in hair care products, the serum includes extracellular vesicles derived from the plant Centella asiatica.

These vesicles are microscopic structures that carry signals between cells and are believed to influence hair follicle behavior. The serum also contains fibroblast growth factor 7 and insulin-like growth factor 1, both of which are associated with supporting hair growth at a cellular level.

The combination of these elements is designed to encourage more hair follicles to enter the active growth phase, rather than remaining dormant.

A Structured and Layered Testing Approach

Researchers divided participants into multiple groups, each receiving a slightly different version of the serum. Some groups were given only basic ingredients, while others received additional growth factors or plant-derived components.

The most advanced version, which combined all elements, produced the strongest results. Measurements taken at regular intervals showed consistent improvements in hair density, thickness, and overall scalp condition.

This step-by-step design allowed researchers to observe how each component contributed to the outcome, suggesting that the combined formula delivered the most effective results.

Representative photographs of the participants in Group E on Day 0 and Day 56 after treatment. (Photo Credit: medRxiv)

Important Limitations to Consider

Despite the encouraging findings, the study has several limitations that prevent definitive conclusions at this stage. The trial lasted only eight weeks, which is relatively short given that hair growth cycles typically span several months.

Additionally, participants were healthy adults rather than individuals diagnosed with pattern hair loss, which means the results may not directly apply to those experiencing more advanced hair thinning.

There are also questions about potential bias, as individuals involved in developing the product were part of the research process. Independent studies will be necessary to validate these findings and confirm their reliability.

How It Fits Into Existing Hair Research

Hair growth is governed by cycles that include resting and active phases, with treatments generally aiming to extend the growth phase, known as anagen. The biological signals used in this serum, such as IGF-1 and FGF-7, are already known to influence these processes in laboratory studies.

The inclusion of Centella asiatica, a plant commonly used in skincare research, adds another layer of interest. Early studies suggest it may support scalp health and reduce inflammation, which could create a more favorable environment for hair growth.

However, commonly used ingredients like caffeine and panthenol are generally associated with improving hair condition rather than directly stimulating new growth.

What Needs to Happen Next

Researchers emphasize that larger and longer-term trials are essential before the serum can be considered a reliable treatment option. Future studies should include individuals with diagnosed hair loss and compare results directly with established treatments such as minoxidil and finasteride.

Monitoring safety will also be critical, particularly because the formula includes biologically active growth signals that could have unintended effects if not carefully controlled.

Consistency in production will be another challenge, especially if plant-derived components play a key role in effectiveness.

What This Means for Consumers

For now, established treatments remain the most dependable options for managing hair loss, as they are supported by extensive clinical evidence and long-term data.

While the new serum shows potential, experts caution against viewing it as a breakthrough solution just yet. Hair growth is a gradual process, and maintaining results typically requires consistent, long-term use.

The current findings offer an encouraging starting point, but further research will determine whether this plant-based approach can move beyond early promise to become a widely trusted treatment.

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

You may also like

Fuel Oil Spill Triggers Water Advisory in Minden Hills

A fuel oil spill in Minden Hills has prompted a drinking water advisory for residents relying on South Lake, after....

Carfentanil Surge Sparks New U.S. Drug Crisis

A quiet life can unravel in seconds. For 36-year-old Michael Nalewaja, it did just days before Thanksgiving 2025. Living in....

From Plague to COVID: Study Reveals Persistent Inequality

A new study comparing victims of a 17th-century plague outbreak with modern-day COVID-19 cases has uncovered a striking pattern: social....

Cognitive Decline Breakthrough: Scientists Identify Single Protein and Potential Cure

A new study on cognitive decline is offering fresh hope by challenging the long-held belief that brain aging is irreversible.....

Common Antidepressant Shows Promise for Long COVID Fatigue

A widely used and affordable antidepressant may offer relief for one of the most persistent symptoms of long COVID—fatigue—according to....

COVID-19 Cicada Variant BA.3.2 Spreads Globally as Experts Monitor Mutation Risks

A new COVID-19 strain, widely referred to as the “Cicada” variant, is drawing attention as it gradually spreads across multiple....

Medication Costs Hit Black Canadians Harder, Study Finds

A new study has uncovered a troubling gap in Canada’s healthcare system: Black Canadians are significantly more likely to skip....

Meningitis B Vaccine Campaign Gains Urgency After Teen Death and Kent Outbreak

A grieving mother’s call for wider access to the meningitis B vaccine is gaining renewed attention as a recent outbreak....

P.E.I. Health Advocates Urge Ottawa to Act on Alberta’s Bill 11

Health advocates in Prince Edward Island are urging federal action against Alberta’s Bill 11, warning the controversial legislation could reshape....

COVID Still Disrupts Lives Years After Infection

For Mike Hall, life changed dramatically in the summer of 2022. What began as a COVID-19 infection for his wife....

Cancer Advocates Urge Colon Screening to Start at 45 in Canada

The Canadian Cancer Society is calling on provinces and territories to lower the starting age for colorectal cancer screening, citing....

FDA Says Autism Claims Around Drug Lack Strong Evidence

The U.S. Food and Drug Administration has approved a generic medication for an extremely rare neurological disorder but says there....